Social Emotional Development in Young Children With Cancer
| Status: | Recruiting |
|---|---|
| Healthy: | No |
| Age Range: | 4 - 6 |
| Updated: | 11/29/2018 |
| Start Date: | July 11, 2017 |
| End Date: | September 2024 |
| Contact: | Victoria W. Willard, PhD |
| Email: | referralinfo@stjude.org |
| Phone: | 866-278-5833 |
Many children with cancer are diagnosed in early childhood, and as such, will likely miss key
social experiences such as participation in preschool or kindergarten, playing on
playgrounds, and other normative experiences. In typically-developing children, it is known
that these experiences - and the skills that are learned during them - are critical to later
well-being. Very little is known about the psychological functioning of young children with
cancer, as studies have predominantly focused on those who are older (at least 8 years of
age). This study will explicitly assess social functioning in preschool-aged children with
cancer and follow the development of their social functioning from the end of treatment into
survivorship.
The goals of this pilot study are to begin to assess the impact of missed early childhood
social experiences, as well as the interaction with developing neurocognitive problems.
PRIMARY OBJECTIVE: Explore the impact of cancer in the central nervous system on social
functioning of young children (ages 4-6) after completion of therapy.
social experiences such as participation in preschool or kindergarten, playing on
playgrounds, and other normative experiences. In typically-developing children, it is known
that these experiences - and the skills that are learned during them - are critical to later
well-being. Very little is known about the psychological functioning of young children with
cancer, as studies have predominantly focused on those who are older (at least 8 years of
age). This study will explicitly assess social functioning in preschool-aged children with
cancer and follow the development of their social functioning from the end of treatment into
survivorship.
The goals of this pilot study are to begin to assess the impact of missed early childhood
social experiences, as well as the interaction with developing neurocognitive problems.
PRIMARY OBJECTIVE: Explore the impact of cancer in the central nervous system on social
functioning of young children (ages 4-6) after completion of therapy.
Participants will be evaluated using the same or similar questionnaires at two time points.
The first assessment will take place when they are 6-12 months post the end of treatment.
Participants and their parents/legal guardian will complete an assessment of social and
cognitive functioning by completing questionnaires about social, emotional, behavioral, and
executive functioning. If the study participant agrees, they will identify another adult
(that is, teacher or daycare employee) who may be contacted to complete questionnaires about
the participant's social and behavioral functioning. A follow-up study visit will occur about
two years later.
The first assessment will take place when they are 6-12 months post the end of treatment.
Participants and their parents/legal guardian will complete an assessment of social and
cognitive functioning by completing questionnaires about social, emotional, behavioral, and
executive functioning. If the study participant agrees, they will identify another adult
(that is, teacher or daycare employee) who may be contacted to complete questionnaires about
the participant's social and behavioral functioning. A follow-up study visit will occur about
two years later.
Inclusion Criteria:
- Primary Diagnosis of a brain or non-CNS solid tumor
- Between 4 and 6 years of age at enrollment
- Between 6 and 12 months post-therapy at the time of enrollment
- Treatment plan included chemotherapy
- English speaking
- Cognitive and language capacity to complete measures
Exclusion Criteria:
- Diagnosis of a genetic disorder/pre-existing neurodevelopmental condition associated
with neurocognitive or social impairment (e.g., autism, Neurofibromatosis Type 1
(NF1), Down syndrome)
- Solid tumor patients who required CNS-directed therapy (e.g., radiation, intrathecal
chemotherapy)
- Inability or unwillingness of research participant or legal guardian/representative to
give written informed consent.
We found this trial at
1
site
262 Danny Thomas Pl
Memphis, Tennessee 38105
Memphis, Tennessee 38105
(901) 495-3300
Principal Investigator: Victoria W. Willard, PhD
Phone: 866-278-5833
St. Jude Children's Research Hospital St. Jude is unlike any other pediatric treatment and research...
Click here to add this to my saved trials
